Brown Brothers Harriman & Co. Has $1.93 Million Position in CME Group Inc. (NASDAQ:CME)

Brown Brothers Harriman & Co. lowered its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 24.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,761 shares of the financial services provider's stock after selling 2,785 shares during the quarter. Brown Brothers Harriman & Co.'s holdings in CME Group were worth $1,933,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. grew its position in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock worth $444,443,000 after acquiring an additional 1,309,097 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock valued at $126,872,000 after purchasing an additional 550,133 shares during the period. Ameriprise Financial Inc. grew its position in CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock worth $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. International Assets Investment Management LLC grew its position in CME Group by 21,465.5% in the 3rd quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider's stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the last quarter. Finally, Baillie Gifford & Co. acquired a new stake in shares of CME Group in the third quarter valued at approximately $79,692,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

Shares of NASDAQ CME traded up $5.02 during mid-day trading on Tuesday, reaching $234.39. The company had a trading volume of 2,752,770 shares, compared to its average volume of 1,926,907. The company has a 50-day moving average price of $224.18 and a two-hundred day moving average price of $211.37. The stock has a market cap of $84.47 billion, a PE ratio of 24.65, a P/E/G ratio of 5.28 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $235.18.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.25 EPS. On average, equities analysts anticipate that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 1.96%. The ex-dividend date of this dividend is Monday, December 9th. CME Group's payout ratio is 48.37%.

Insider Buying and Selling at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 5.38 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock valued at $3,441,063 in the last three months. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CME has been the subject of a number of analyst reports. Oppenheimer boosted their price target on CME Group from $245.00 to $258.00 and gave the stock an "outperform" rating in a research report on Thursday, October 24th. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a report on Thursday, October 3rd. TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a "hold" rating and a $221.00 target price on the stock. Redburn Atlantic downgraded shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target on the stock. in a research report on Tuesday, October 8th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an "equal weight" rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.